Antibody name Specific terminal, binding to specific amino acid domain, biding at S1-protein SARS-CoV-1 RBD Cited in reference
CR3022 C-Terminal RBD, 318-510 amino acid residue, Showed cross reactivity with SARS-CoV-2 48
F26G18 C-Terminal of RBD, 460-476 amino acid residues 52
4D4 N-Terminal of RBD, 12-261 amino acid residues, inhibiting the post-interaction in the viral penetration in vitro 53
CR3014 C-terminal of RBD, 318-510 amino acid residues and 565 amino acid residue (high affinity) but do not showed cross reactive to SARS-CoV-2 48,50
68 130-150 of the amino acid residues 54
80R C-Terminal of RBD, 426-492 amino acid residues, blocking the interaction of S1 subunit protein with cellular receptor ACE2 using 6 complementary determining region (CDR) in vitro and in vivo (Mouse 55
F26G19 C-Terminal of RBD, 359-362, 391-392, 424-427, and 486-492 amino acid residues 52
201 C-Terminal of RBD, 490-510 amino acid residues, 56
1A9 Binding to the Heptad repeat (HR) loops including heptad repeat 1 (HR1) and heptad repeat 1 (HR2) domain on S2 fragment, 1111-1130 amino acid residues 57,58
S230 Binding to epitopes partially overlapping with receptor binding motifs on B domain of SARS-CoV-1, Blocking the interaction of S1 subunit protein with cellular receptor ACE2 in vitro 59
m396 C-Terminal, 482-491 amino acid residues 51,52